Extracellular ADP activates NLRP3 inflammasomes via P2Y1 receptor-mediated calcium signaling, and deletion of P2Y1 receptors or treatment with P2Y1 receptor inhibitors inhibits NLRP3 inflammasomes activation to alleviate colitis (Zhang et al., 2020). The gene discussed is NLRP3; the disease is colitis.